Latest filing published 23 Feb 2023 for Capricor Therapeutics, INC., €1,824.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +12.9%Entry US$11.60 · Close at T+365 US$13.10
- +12.7%Entry US$27.50 · Close at T+365 US$31.00
- -60.8%Entry US$58.20 · Close at T+365 US$22.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Louis Manzo: trading record in brief
All filings by Louis Manzo on record concern Capricor Therapeutics, Inc., in the capacity of board member. In total, 10 filings cover trades dated from 21 January 2015 to 21 February 2023.
The open-market record is one-sided, with 3 purchases worth €331k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 2 share grants and 4 option exercises.
A typical purchase (the median) is worth €87k. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +1.4%. They describe history only and say nothing certain about the share price ahead.
On 23 February 2023 came the latest disclosure, a transaction for €1,824 in Capricor Therapeutics, Inc. The last purchase on record was published on 11 May 2017, which is 3,469 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Louis Manzo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 452 shares@ US$4.310.5% of flowCommon StockSEC:0001415889-23-003084:1
- 1,401 shares@ US$1.394.9% of flowCommon StockSEC:0001415889-23-003084:0
- 11,309 shares@ US$3.4310.1% of flowCommon StockSEC:0001415889-22-003580:1
- 27,904 shares@ US$1.3995.1% of flowCommon StockSEC:0001415889-22-003580:0
- 8,299 shares@ US$3.7041.6% of flowCommon StockSEC:0001104659-20-109138:0
- 20,391 sharesCommon StockSEC:0001104659-19-074513:0
- 20,748 shares@ US$0.160.9% of flowCommon StockSEC:0001144204-17-053990:0
- 10,000 shares@ US$3.109.2% of flowCommon StockSEC:0001144204-17-026396:0Canonical exit: 7 Aug 2017 (T+90)
- 100,000 shares@ US$2.4069.6% of flowCommon StockSEC:0001144204-16-089003:0Canonical exit: 14 Jun 2016 (T+90)
- 28,384 shares@ US$3.52Common StockSEC:0001144204-15-003367:0Canonical exit: 21 Apr 2015 (T+90)
10 of 10 declarations
